European Manufacturing Giant Selects Labvantage
News Apr 25, 2012
LABVANTAGE has announced that an European manufacturing giant has selected its LIMS solution to replace its existing LIMS to meet GLP-requirements at its R&D headquarters. The solution will manage next generation product testing, part of the research and development pipeline, for key functionality such as stability testing, chemistry, and physicochemical testing. LABVANTAGE provides a user-friendly, intuitive and configurable GUI, delivered entirely via thin-client web browser. The new LIMS will also manage the facility’s extensive library of study protocols while enabling better decision making through its advanced reporting and analytics. LABVANTAGE’s Advanced Storage and Logistics, CAPA (Corrective Actions, Preventive Actions) and Connect Advanced Instrument Interface will also be deployed.
“This project provides an out-of-the-box LIMS solution that fully fits into the customer’s existing product life-cycle management process and further validates our investment into this part of the customer enterprise. We remain confident that our substantial investments into our own product portfolio will continue to extend our competitive differentiation in this legacy replacement market,” says Jeff Ferguson, LABVANTAGE Chief Executive Officer.
The implementation will be deployed in three phases: analysis request, logistics, and chemistry assessment-related analyses in phase one; product development support, batch release support and stability for phase two; and in vitro testing for phase three.
A new platform ensures that web services adhere to users’ preferences on how their data are stored and shared in the cloud. In a paper being presented at this week’s USENIX Networked Systems Design and Implementation conference, the researchers behind the platform, called Riverbed, show how it forces data center servers to only use data in ways that users explicitly approve.READ MORE
Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE